Quality of life as an outcome indicator in patients with seasonal affective disorder: Results from the Can-SAD study

Psychological Medicine

Volumn 37, Issue 5, 2007, Pages 727-736

  Michalak, Erin E ^a   Murray, Greg ^b   Levitt, Anthony J ^c,d   Levitan, Robert D ^c,e   Enns, Murray W ^f   Morehouse, Rachel ^g   Tam, Edwin M ^a   Cheung, Amy ^c,d   Lam, Raymond W ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b SWINBURNE UNIVERSITY OF TECHNOLOGY   (Australia)

^c UNIVERSITY OF TORONTO   (Canada)

^d SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^e CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^f UNIVERSITY OF MANITOBA   (Canada)

^g DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; FLUOXETINE; PLACEBO;

ADULT; ARTICLE; CANADA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PHOTOTHERAPY; PSYCHOTHERAPY; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SEASONAL AFFECTIVE DISORDER; STATISTICAL SIGNIFICANCE; TREATMENT DURATION; TREATMENT OUTCOME; WINTER;

ADULT; CANADA; DOUBLE-BLIND METHOD; FEMALE; FLUOXETINE; HUMANS; MALE; PHOTOTHERAPY; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; SEASONAL AFFECTIVE DISORDER; SEROTONIN UPTAKE INHIBITORS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 34047174660     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291706009378     Document Type: Article

References (43)

1. Allen, J. M., Lam, R. W., Remick, R. A. & Sadovnick, A. D. (1993). Depressive symptoms and family history in seasonal and nonseasonal mood disorders. American Journal of Psychiatry 150, 443-448.
2. American Psychiatric Association (2000). Practice guideline for the treatment of patients with major depressive disorder (revision). American Journal of Psychiatry 157 (Suppl.), 1-45.
3. Atkinson, M., Zibin, S. & Chuang, H. (1997). Characterizing quality of life among patients with chronic mental illness : A critical examination of the self-report methodology. American Journal of Psychiatry 154, 99-105.
4. Bauer, M., Whybrow, P. C., Angst, J., Versiani, M. & Moller, H.-J., WFSBP Task Force on Treatment Guidelines for Unipolar Depressive Disorders (2002). World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, Part 1: Acute and continuation treatment of major depressive disorder. World Journal of Biological Psychiatry 3, 5-43.
5. Blazer, D. G., Kessler, R. C. & Swartz, M. S. (1998). Epidemiology of recurrent major and minor depression with a seasonal pattern. The National Comorbidity Survey. British Journal of Psychiatry 172, 164-167.
6. Cooke, R. G., Robb, J. C., Young, L. T. & Joffe, R. T. (1996). Wellbeing and functioning in patients with bipolar disorder assessed using the MOS 20-item short form (SF-20). Journal of Affective Disorders 39, 93-97.
7. Endicott, J., Nee, J., Harrison, W. & Blumenthal, R. (1993). Quality of Life Enjoyment and Satisfaction Questionnaire: A new measure. Psychopharmacological Bulletin 29, 321-326.
8. Golden, R. N., Gaynes, B. N., Ekstrom, R. D., Hamer, R. M., Jacobsen, F. M., Suppes, T., Wisner, K. L. & Nemeroff, C. B. (2005). The efficacy of light therapy in the treatment of mood disorders: A review and meta-analysis of the evidence. American Journal of Psychiatry 162, 656-662.
9. Kennedy, S. H., Lam, R. W., Cohen, N. L. & Ravindran, A. V. (2001). Clinical guidelines for the treatment of depressive disorders. IV. Medications and other biological treatments. Canadian Journal of Psychiatry 46 (Suppl. 1), 38S-58S.
10. Koran, L. M., Hackett, E., Rubin, A., Wolkow, R. & Robinson, D. (2002). Efficacy of sertraline in the long-term treatment of obsessive-compulsive disorder. American Journal of Psychiatry 159, 88-95.
11. Lam, R. W., Gorman, C. P., Michalon, M., Steiner, M., Levitt, A. J., Corral, M. R., Watson, G. D., Morehouse, R. L., Tam, W. & Joffe, R. T. (1995). Multicenter, placebo-controlled study of fluoxetine in seasonal affective disorder. American Journal of Psychiatry 152, 1765-1770.
12. Lam, R. W. & Levitt, A. J. (1999). Canadian Consensus Guidelines for the Treatment of Seasonal Affective Disorder. Clinical and Academic Publishing: Vancouver, BC.
13. Lam, R. W., Levitt, A. J., Levitan, R. D., Enns, M. W., Morehouse, R. L., Michalak, E. E. & Tam, E. M. (2006). The CAN-SAD study: Randomized controlled trial of the effectiveness of light therapy and fluoxetine in patients with winter seasonal affective disorder. American Journal of Psychiatry 163, 805-812.
14. Lee, T. M. & Chan, C. C. (1999). Dose-response relationship of phototherapy for seasonal affective disorder: A meta-analysis. Acta Psychiatrica Scandinavica 99, 315-323.
15. Leonhardt, G.,Wirz-Justice, A., Krauchi, K., Graw, P., Wunder, D. & Haug, H. J. (1994). Long-term follow-up of depression in seasonal affective disorder. Comprehensive Psychiatry 35, 457-464.
16. Levitt, A. J. & Boyle, M. H. (2002). The impact of latitude on the prevalence of seasonal depression. Canadian Journal of Psychiatry 47, 361-367.
17. Levitt, A. J., Boyle, M. H., Joffe, R. T. & Baumal, Z. (2000). Estimated prevalence of the seasonal subtype of major depression in a Canadian community sample. Canadian Journal of Psychiatry 45, 650-654.
18. Linzer, M., Spitzer, R., Kroenke, K.,Williams, J. B., Hahn, S., Brody, D. & deGruy, F. (1996). Gender, quality of life, and mental disorders in primary care: Results from the PRIME-MD 1000 study. American Journal of Medicine 101, 526-533.
19. Lonnqvist, J., Sihvo, S., Syvalahti, E. & Kiviruusu, O. (1994). Moclobemide and fluoxetine in atypical depression: A doubleblind trial. Journal of Affective Disorders 32, 169-177.
20. Michalak, E. E., Murray, G. W., Young, A. H. & Lam, R. W. (in press). Quality of life impairment in bipolar disorder. In Quality of Life Impairment in Schizophrenia, Mood and Anxiety Disorders: From Brain Functions to Clinical Practice (ed. M. Ritsner). Springer.
21. Michalak, E. E., Tam, E. M., Manjunath, C. V., Levitt, A. J., Levitan, R. D. & Lam, R. W. (2005). Quality of life in patients with seasonal affective disorder: Summer vs winter scores. Canadian Journal of Psychiatry 50, 292-295.
22. Michalak, E. E., Tam, E. M., Manjunath, C. V., Solomons, K., Levitt, A. J., Levitan, R., Enns, M., Morehouse, R., Yatham, L. N. & Lam, R. W. (2004). Generic and health-related quality of life in patients with seasonal and nonseasonal depression. Psychiatry Research 128, 245-251.
23. Michalak, E. E., Wilkinson, C., Dowrick, C. & Wilkinson, G. (2001). Seasonal affective disorder : Prevalence, detection and current treatment in North Wales. British Journal of Psychiatry 179, 31-34.
24. Michalak, E. E., Wilkinson, C., Hood, K. & Dowrick, C. (2002). Seasonal and nonseasonal depression: How do they differ? Symptom profile, clinical and family history in a general population sample. Journal of Affective Disorders 69, 185-192.
25. Miller, I. W., Keitner, G. I., Schatzberg, A. F., Klein, D. N., Thase, M. E., Rush, A. J., Markowitz, J. C., Schlager, D. S., Kornstein, S. G., Davis, S. M., Harrison, W. M. & Keller, M. B. (1998). The treatment of chronic depression, part 3: Psychosocial functioning before and after treatment with sertraline or imipramine. Journal of Clinical Psychiatry 59, 608-619.
26. Moscovitch, A., Blashko, C. A., Eagles, J. M., Darcourt, G., Thompson, C., Kasper, S. & Lane, R. M. (2004). A placebo-controlled study of sertraline in the treatment of outpatients with seasonal affective disorder. Psychopharmacology (Berlin) 171, 390-397.
27. Murray, G., Michalak, E. E., Levitt, A. J., Levitan, R. D., Enns, M. W., Morehouse, R. & Lam, R. W. (2005a). O sweet spot where art thou? Light treatment of Seasonal Affective Disorder and the circadian time of sleep. Journal of Affective Disorders 90, 227-231.
28. Murray, G., Michalak, E. E., Levitt, A. J., Levitan, R. D., Enns, M. W., Morehouse, R. & Lam, R. W. (2005b). Therapeutic mechanism in seasonal affective disorder: Do fluoxetine and light operate through advancing circadian phase? Chronobiology International 22, 937-943.
29. Partonen, T. & Lonnqvist, J. (1996). Moclobemide and fluoxetine in treatment of seasonal affective disorder. Journal of Affective Disorders 41, 93-99.
30. Pendse, B. P., Engstrom, G. & Traskman-Bendz, L. (2004). Psychopathology of seasonal affective disorder patients in comparison with major depression patients who have attempted suicide. Journal of Clinical Psychiatry 65, 322-327.
31. Rapaport, M. H., Clary, C., Fayyad, R. & Endicott, J. (2005). Quality-of-life impairment in depressive and anxiety disorders. American Journal of Psychiatry 162, 1171-1178.
32. Rapaport, M. H., Clary, C. M. & Judd, L. L. (2001). The impact of depression and its treatment. Presented at the 154th Annual Meeting of the American Psychiatric Association, New Orleans, LA, 2001.
33. Rapaport, M. H., Endicott, J. & Clary, C. M. (2002). Posttraumatic stress disorder and quality of life : Results across 64 weeks of sertraline treatment. Journal of Clinical Psychiatry 63, 59-65.
34. Rapaport, M. H., Pollack, M., Wolkow, R., Mardekian, J. & Clary, C. (2000). Is placebo response the same as drug response in panic disorder ? American Journal of Psychiatry 157, 1014-1016.
35. Rosenthal, N. E., Sack, D. A., Gillin, J. C., Lewy, A. J., Goodwin, F. K., Davenport, Y., Mueller, P. S., Newsome, D. A. & Wehr, T. A. (1984). Seasonal affective disorder: A description of the syndrome and preliminary findings with light therapy. Archives of General Psychiatry 41, 72-80.
36. Schlager, D., Froom, J. & Jaffe, A. (1995). Winter depression and functional impairment among ambulatory primary care patients. Comprehensive Psychiatry 36, 18-24.
37. Shi, L., Namjoshi, M. A., Zhang, F., Gandhi, G., Edgell, E. T., Tohen, M., Breier, A. & Haro, J. M. (2002). Olanzapine versus haloperidol in the treatment of acute mania: Clinical outcomes, healthrelated quality of life and work status. International Clinical Psychopharmacology 17, 227-237.
38. Sintonen, H. (1998). The use of health indexes in calculating health gains (QALYs). In Health Statistics. Joint ECE/WHO Meeting Proceedings, 14-16 October 1998, Rome, Italy.
39. Stewart, A. L., Hays, R. D. & Ware Jr., J. E. (1988). The MOS shortform general health survey. Reliability and validity in a patient population. Medical Care 26, 724-735.
40. Strejilevich, S. A., Palatnik, A., Avila, R., Bustin, J., Cassone, J., Figueroa, S., Gimenez, M. & de Erausquin, G. A. (2005). Lack of extrapyramidal side effects predicts quality of life in outpatients treated with clozapine or with typical antipsychotics. Psychiatry Research 133, 277-280.
41. Thompson, C. (2001). Evidence-based treatment. In Seasonal Affective Disorder: Practice and Research (ed. T. Partonen and A. Magnusson), pp. 151-158. Oxford University Press: New York.
42. Williams, J. B. W., Gibbon, M. & First, M. B. (1992). The Structured Clinical Interview for DSM-III-R (SCID). I : History, rationale, and description. Archives of General Psychiatry 49, 624-629.
43. Williams, J. B. W., Link, M. J., Rosenthal, N. E. & Terman, M. (1988). Structured Interview Guide for the Hamilton Depression Rating Scale, Seasonal Affective Disorders Version (SIGH-SAD). New York Psychiatric Institute: New York.